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RIF1 interaction with PP1 and prevents
the accumulation of DNA damage and
breaks. This discovery highlights the
importance of RIF1 in maintaining
genomic stability when DNA replication is
challenged.
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RIF1 is a multifunctional protein implicated in con-
trolling DNA replication and repair. Here, we show
that human RIF1 protects nascent DNA from over-
degradation at stalled replication forks. The major
nuclease resecting nascent DNA in the absence of
RIF1 is DNA2, operating with WRN as an accessory
helicase. We show that RIF1 acts with protein phos-
phatase 1 to prevent over-degradation and that RIF1
limits phosphorylation of WRN at sites implicated in
resection control. Protection by RIF1 against inap-
propriate degradation prevents accumulation of
DNA breakage. Our observations uncover a crucial
function of human RIF1 in preventing genome insta-
bility by protecting forks from unscheduled DNA2-
WRN-mediated degradation.INTRODUCTION
Accurate DNA replication is essential to maintain genomic
stability through successive cell cycles. Genome duplication is,
however, challenged by threats such as DNA lesions, collisions
with the transcription machinery, and nucleotide pool depletion
(Zeman and Cimprich, 2014). Preserving the integrity of stalled
replication forks is essential to prevent genome instability-
inducing events that may cause oncogenesis. Cells rely on
various mechanisms to protect against replication-related dam-
age, including S phase checkpoint activation, which stabilizes
protein complexes at stalled forks and suppresses late origin
firing to delay cell-cycle progression (Smith et al., 2010).
An additional layer of control emerged with the understanding
that the tumor suppressor protein BRCA2, traditionally associ-
ated with homologous recombination repair, also protects
nascent DNA at stalled replication forks (Schlacher et al.,
2011). Specifically, upon treatment with the replication inhibitor
hydroxyurea (HU), BRCA2-defective cells showed increased
degradation of nascent DNA strands. This resection is due to
MRE11 nuclease and is caused by the inability of BRCA2-defi-
cient cells to stabilize RAD51 nucleofilaments at blocked forks
(Schlacher et al., 2011, 2012). Recent studies have revealed2558 Cell Reports 27, 2558–2566, May 28, 2019 ª 2019 The Author(s
This is an open access article under the CC BY license (http://creativethe molecular mechanisms underlying resection in BRCA1-
and BRCA2-defective cells, by demonstrating that reversed
replication forks act as the entry point for the nucleolytic degra-
dation (Lemac¸on et al., 2017; Mijic et al., 2017; Taglialatela et al.,
2017). Various nucleolytic pathways appear to be differentially
regulated by distinct fork protective proteins. The DNA2
nuclease promotes nucleolytic degradation after prolonged HU
treatment in wild-type U2OS cells (Thangavel et al., 2015),
although DNA2 is not the major nuclease responsible for resec-
tion in the BRCA mutants (Lemac¸on et al., 2017). Factors that
limit DNA2-mediated processing include the Abraxas paralog
Abro1, BOD1L, and CtIP (Higgs et al., 2015; Przetocka et al.,
2018; Xu et al., 2017a). UnscheduledDNA2-dependent degrada-
tion of newly replicated DNA in the absence of these proteins
causes catastrophic genome instability upon replication fork
stalling. The importance of the nascent DNA protection path-
ways was underscored by a study identifying the acquisition of
nascent DNA protection as a new mechanism for the develop-
ment of chemoresistance in BRCA-deficient tumor cells (Ray
Chaudhuri et al., 2016).
RIF1 has emerged as a multifunctional chromosome stability
protein playing diverse roles in mammalian cells. In double-
strand break (DSB) repair, mammalian RIF1 acts with 53BP1 to
promote non-homologous end joining by antagonizing BRCA1-
mediated processing of the break ends (Chapman et al., 2013;
Escribano-Dı´az et al., 2013). RIF1 also negatively regulates
DNA initiation at replication origins in both yeast and human
cells by acting as a protein phosphatase 1 (PP1) substrate-tar-
geting subunit (Hiraga et al., 2014, 2017), counteracting the
Dbf4-dependent kinase (DDK)-dependent phosphorylation that
activates the minichromosome maintenance protein (MCM)
complex as the major replicative helicase. Interaction of PP1
with its substrate-targeting subunits is mediated through char-
acteristic amino acid motifs (RVxF and SILK sequences). Human
RIF1 contains three such PP1-interacting motifs, which mediate
its association with PP1 and are required for RIF1 to negatively
regulate replication initiation (Hiraga et al., 2017).
RIF1-deficient cells are hypersensitive to several replication
inhibitors (Buonomo et al., 2009; Xu et al., 2017b), and human
RIF1 localizes to replication forks independently of 53BP1 (Ala-
bert et al., 2014). However, the specific role of RIF1 at stalled
forks and its response to replication inhibition has remained
largely unclear. Here, we show that through its interaction).
commons.org/licenses/by/4.0/).
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Figure 1. RIF1 Prevents DNA Resection at
Stalled Forks through PP1 Interaction
(A) Schematic diagram of fork protection assay.
(B) Nascent DNA degradation analysis in HEK293-
derived cell lines transfected with siControl or
siRIF1 and expressing constructs indicated. Cells
were treated with HU 2 mM for 4 h before fiber
analysis. For fiber analysis through the whole
study, at least 100 forks were evaluated per con-
dition. The bar reflects the median value, and the
statistical analysis was performed using the Mann-
Whitney test.
(C) Resection of nascent DNA in U2OS cells,
evaluated as in (B). Cells were mock treated or
treated with tautomycetin at 5 mM, as indicated.
ns, not significant; ****p% 0.0001.with PP1, human RIF1 prevents the untimely degradation of
newly replicated DNA at replication forks challenged with HU.
Moreover, we identify DNA2, acting with the Werner’s helicase
protein WRN, as the major nuclease-helicase complex that
drives the uncontrolled resection of nascent DNA in the
absence of RIF1. We find that RIF1 regulates WRN helicase
phosphorylation at residues implicated in the control of resec-
tion. We also reveal that nascent strand protection by RIF1
is essential to prevent the accumulation of DNA damage in
HU-treated cells.
RESULTS
RIF1 Protects Nascent DNA fromDegradation upon Fork
Stalling through Its Interaction with Protein
Phosphatase 1
RIF1-deficient cells have been reported to show hypersensitivity
to some replication inhibitors, highlighting the importance of
RIF1 in replication stress survival. These observations prompted
us to investigate any role for human RIF1 in controlling nascent
DNA stability upon replication blockage. We first performed
DNA fiber analysis to test whether the absence of RIF1 leads
to unscheduled resection of the newly replicated DNA. Cells
were treated successively with the thymidine analogs 5-chloro-
2ʹ-deoxyuridine (CldU) and 5-iodo-2ʹ-deoxyuridine (IdU), fol-
lowed by HU treatment (Figure 1A). Immunodetection-based
visualization of the IdU- and CldU-labeled tracts on DNA fibers
then allows the extent of the degradation of nascent DNA to be
monitored by assessing the IdU:CldU length ratio. To test
RIF1 function at stalled forks, we used previously establishedCell RHEK293-derived cell lines (Hiraga et al.,
2017), which contain doxycycline (DOX)-
inducible cDNA constructs encoding
GFP-fused RIF1, or GFP as a control.
Depletion of endogenous RIF1 from the
control cell line caused significantly
increased resection of the IdU tract
when compared to small interfering con-
trol RNA (siControl)-transfected cells (Fig-
ure 1B, columns 1 and 2, GFP samples),
suggesting a role for RIF1 in protectingnascent DNA upon fork stalling. DOX-induced expression of
GFP-RIF1 prevented the degradation of nascent DNA in this
endogenous RIF1-depleted background, confirming the speci-
ficity of siRIF1 treatment and the functionality of the GFP-RIF1
protein (Figure 1B, GFP-RIF1).
Since several roles of RIF1 require its interaction with PP1
(Hiraga et al., 2014, 2017; Kedziora et al., 2018), we tested
whether PP1 may mediate this effect of RIF1 at stalled forks.
For this purpose, we used a cell line containing a DOX-inducible
construct encoding aGFP-fusedmutant RIF1 (GFP-RIF1-pp1bs)
that has all three PP1-interaction motifs mutated so that it can no
longer bind PP1 (Hiraga et al., 2017). The GFP-RIF1 and GFP-
RIF1-pp1bs constructs are resistant to siRNA knockdown due
to synonymous base substitutions. The depletion of endogenous
RIF1, followed by the induction of GFP-RIF1-pp1bs failed to
restore the IdU:CldU ratio (Figure 1B, GFP-RIF1-pp1bs), in
contrast to GFP-RIF1. The association of PP1 with RIF1 is there-
fore required to preserve the integrity of nascent DNA at blocked
forks. In unperturbed conditions, the IdU:CldU ratio was unaf-
fected by RIF1 knockdown or by the expression of GFP-fused
constructs (Figures S1A and S1B), confirming that these effects
reflect events that occur after fork blocking and not during
normal replication. CldU tract length was slightly increased in
RIF1-depleted cells before HU addition when compared to
siControl (Figure S1C), suggesting a slightly (26%) increased
progression rate of unperturbed forks in the absence of RIF1.
The difference is statistically significant in this study, probably
due to the higher number of forks analyzed here when compared
to previous investigations (Chapman et al., 2013; Hiraga et al.,
2017) and will be described further elsewhere.eports 27, 2558–2566, May 28, 2019 2559
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Figure 2. RIF1 Depletion Leads to Increased
ssDNA Regions, Hyperactivation of S Phase
Checkpoint, and Increased Sensitivity to HU
(A) RPA nuclear foci analyzed by immunofluorescence
in siControl or siRIF1-treated HEK293 cells. HU treat-
ment was 2 mM for 4 h. Cells were pre-extracted to
detect only chromatin-bound RPA. Left, representative
images (scale bars, 10 mm). Right, quantification of RPA
integrated intensity per nucleus.
(B) Whole-cell extracts from HEK293 cells transfected
with siControl or siRIF1 analyzed by immunoblotting
with the indicated antibodies. HU treatment was 2 mM
for 4 h.
(C) Clonogenic assay. HEK293 cells were transfected
with siControl or siRIF1, treated (or not) with 4 mM HU
for 8 h, then cell viability was assessed by counting
surviving colonies 7 days after treatment (n = 3 biolog-
ical replicates). Error bars represent SD.
ns, not significant; **p < 0.01; ****p% 0.0001.We tested whether the role of RIF1 in nascent DNA fork pro-
tection was conserved in another human cell line. In U2OS cells,
RIF1 depletion also caused a reduced IdU:CldU ratio after treat-
ment with HU (Figure 1C). Moreover, the chemical inhibition
of PP1 using tautomycetin caused nascent DNA resection,
mimicking the phenotype of RIF1-depleted cells. Notably, PP1
inhibition did not cause a further increase in degradation in
siRIF1-treated cells, implying that RIF1 and PP1 act in the
same pathway to protect newly replicated DNA. We also tested
replication fork restart capacity in the absence of RIF1, using a
fiber assay that monitors the proportion of forks able to resume
replication, as assessed by their successful incorporation of IdU
after the removal of HU (Figure S1D). However, after treatment
with HU, we found no significant decrease in the percentage of
forks that were able to restart in the absence of RIF1 (Figure S1D,
left panel) or difference in IdU tract length (Figure S1D, right
panel).
These results demonstrate that RIF1, through its association
with PP1, protects nascent DNA from degradation upon fork
stalling due to HU. RIF1 is, however, dispensable for the resump-
tion of DNA synthesis.
RIF1-Depleted Cells Accumulate ssDNA, Hyperactivate
the S Phase Checkpoint, and Show Hypersensitivity to
HU Treatment
Abnormal resection of nascent DNA occurring at stalled forks in
the absence of RIF1 could lead to longer stretches of single-
stranded DNA (ssDNA), so we examined replication protein A
(RPA) foci as a readout for ssDNA accumulation. Staining
RIF1-depleted cells revealed an increase in the integrated RPA
signal per nucleus compared to controls (Figure 2A). We also
observed hyperphosphorylation of Chk1-Ser345 upon HU2560 Cell Reports 27, 2558–2566, May 28, 2019treatment of cells lacking RIF1 (Figure 2B), re-
flecting hyperactivation of the S phase check-
point under replication stress conditions when
RIF1 is not present. These data suggest that
unscheduled degradation in the absence of
RIF1 contributes to the generation ofextended ssDNA regions, leading to increased activation of the
S phase checkpoint. Moreover, we observed a reduced viability
of RIF1-depleted cells treated with HU (Figure 2C), as previously
reported.
These results highlight the crucial role of RIF1 in preventing
replication stress-associated damage and limiting the activation
of the ATR-Chk1 DNA damage checkpoint pathway.
DNA2 Acts in Conjunction with WRN Helicase to
Promote Resection of Stalled Forks in the Absence
of RIF1
We sought to identify the nucleases responsible for the
increased degradation when RIF1 is not present. Co-depletion
of DNA2 and RIF1 considerably ameliorated the nascent DNA
degradation seen in cells lacking RIF1 alone upon fork stalling
(Figure 3A). Treatment with a chemical inhibitor of DNA2,
NSC-105808, similarly suppressed overresection in cells
depleted of RIF1 (Figure S2A). In U2OS cells, simultaneous
removal of DNA2 and RIF1 also protected nascent DNA from
degradation, demonstrating that this resection pathway acts
similarly in another human cell line (Figure S2B). Overall, these
results implicate DNA2 as important for mediating resection in
the absence of RIF1.
We examined whether other nucleases contribute to resection
in RIF1-depleted cells. MRE11 is the major nuclease promoting
degradation at stalled forks in BRCA1, BRCA2, or FANCD2-
defective cells (Schlacher et al., 2011, 2012). However, inhibition
of MRE11 with mirin (Figure 3B) or its depletion by siMRE11 (Fig-
ure S2C) caused only a slight reduction in nascent DNA degrada-
tion in RIF1-deficient cells, with the minor effects observed not
being statistically significant. Nor did EXO1 depletion signifi-
cantly affect the extent of DNA degradation in cells lacking
AB C
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RIF1 (Figure S2D). Overall, these data strongly suggest that RIF1
suppresses specifically DNA2-mediated degradation of newly
replicated DNA at stalled forks, working independently from
the BRCA2-dependent pathway of fork protection. Simulta-
neous BRCA2 depletion increased nascent DNA degradation
compared to RIF1 depletion alone, consistent with the sugges-
tion that RIF1 and BRCA2 operate in separate pathways to sup-
press resection (Figure S2E).
RIF1 is not the first factor that acts in fork protection by sup-
pressing DNA2-mediated degradation. Abro1 and CtIP, for
example, were recently found to limit nucleolytic processing
by preventing DNA2-mediated degradation (Przetocka et al.,
2018; Xu et al., 2017a); co-depletion of CtIP with RIF1 did not
cause increased degradation (Figure S2E), suggesting that
CtIP opposes the same degradation pathway as RIF1.
DNA2 nuclease has been reported to cooperate with either
Bloom’s (BLM) or Werner’s (WRN) helicase to promote DNA
end resection (Nimonkar et al., 2011; Sturzenegger et al.,
2014), so we evaluated the contribution of these helicases. While
BLM depletion did not significantly improve nascent DNA pro-
tection in cells lacking RIF1, co-depletion of WRN with RIF1
largely prevented the extensive degradation (Figures 3C and
S3A), implying that WRN is crucial for the resection of stalled
forks in the absence of RIF1 and suggesting that this helicase
collaborates with DNA2 nuclease in resecting the unprotected
nascent DNA. In vitro studies have shown that humanWRN inter-
acts with DNA2 to stimulate the resection of 50-recessed DNA
ends and degradation of double-stranded DNA (dsDNA) (Pinto
et al., 2016; Sturzenegger et al., 2014). A previous study indi-
cated that stalled forks must be reversed to form the substrate
for DNA2 nuclease (Thangavel et al., 2015), leading us to inves-
tigate the importance of fork reversal for degradation. Upon fork
stalling, RAD51 is needed for fork reversal to occur (Zellweger
et al., 2015). We found that RAD51 depletion from cells lacking
RIF1 suppressed the resection of the nascent DNA (Figure S4A).
Depletion of SMARCAL1, a translocase that is also required for
fork reversal (Be´tous et al., 2012), similarly suppressed degrada-
tion (Figure S4B). These effects strongly suggest that reversed
forks generated upon HU treatment are the main substrate for
degradation by DNA2-WRN when RIF1 is not present.
WRN Is Hyperphosphorylated in the Absence of RIF1
Our DNA fiber experiments implicate PP1 as acting with RIF1 to
prevent nascent DNA degradation, suggesting that protection
requires the dephosphorylation of factor(s) at stalled forks. As
the factors that mediate resection, both DNA2 nuclease and
WRN helicase are potential candidates for dephosphorylationFigure 3. DNA2 and WRN Mediate Nascent DNA Degradation in RIF1-D
(A) HEK293 cells were depleted for RIF1 and/or DNA2, and nascent DNA degra
analyzed by immunoblotting, with the indicated antibodies after siRNA transfect
(B) Fork protection assay after HU-induced fork stalling in control and RIF1-dep
nuclease activity.
(C) Nascent DNA degradation after RIF1, BLM, and/or WRN knockdown in HEK29
(D) Analysis of WRN phosphorylation in RIF1-depleted cells. FLAG-WRN was ov
collected in unperturbed conditions or after treatment with HU 2 mM for 4 h. FLA
Bar charts show the intensity of peptides with the indicated phosphorylation sites
WRN in each sample. HU sample values correspond to the average of two indep
ns, not significant; ***p < 0.001; ****p% 0.0001.
2562 Cell Reports 27, 2558–2566, May 28, 2019by RIF1-PP1. DNA2 phosphorylation status has not been re-
ported to affect its resection activity in higher eukaryotes.
Some evidence is available concerning phosphorylation-medi-
ated regulation of human WRN. In particular, it was reported
that cyclin-dependent kinase 1 (CDK1) phosphorylates WRN
(at S1133) to control DNA2-dependent end resection at DSBs
arising during replication (Palermo et al., 2016). This study,
together with our observation of increased WRN phosphoryla-
tion in RIF1-deficient cells in a preliminary phosphoproteomic
analysis (Hiraga et al., 2017; data not shown), prompted us to
examine WRN as a possible target of RIF1-PP1. Substrates de-
phosphorylated by RIF1-PP1 are expected to show increased
phosphorylation when RIF1 is absent. To identify residues hy-
perphosphorylated under RIF1-deficient replication-blocked
conditions, we performed immunoprecipitation of overex-
pressed FLAG-tagged WRN from siRIF1 or siControl cells,
either in unperturbed cells or after HU treatment (Figure S3B).
Label-free mass spectrometry analysis identified 12 quantifi-
able phosphorylation sites within the WRN sequence. While
most sites were not affected by RIF1 loss (e.g., Serine 440, Fig-
ure 3D, left panel), we identified a cluster of residues in which
RIF1 depletion did affect phosphorylation levels either without
or with HU treatment. Phosphorylation of the S1133 residue
was undetectable in the siControl untreated cells, but it was
prominently observed in RIF1-depleted untreated cells (Fig-
ure 3D, center panel). S1133 phosphorylation was also high
following HU treatment, irrespective of the presence of RIF1.
Moreover, we identified phosphorylation in a group of three
serines at positions 1139–1141 (sequence 1139-SSSQPV-
1144) that showed greatly increased intensity in the RIF1-defi-
cient samples, compared to siControl, in both untreated and
HU-treated conditions (Figure 3D, right panel). CDK-mediated
S1133 phosphorylation was previously shown to promote
resection by DNA2-WRN (Palermo et al., 2016), and phosphor-
ylation of the S1141 residue appears to modulate WRN activity
(Su et al., 2016). Both of these studies focused on the role of
WRN in the context of DSBs arising after camptothecin treat-
ment. Our observations raised the suggestion that upon HU
blockage, phosphorylation of the WRN S1133 site and the
S1139/40/41 cluster may contribute to the aberrant overresec-
tion observed in RIF1-depleted cells. We examined the impact
of mutating these residues in an experiment in which we
depleted endogenous WRN and instead expressed a mutant
4A WRN protein replacing serine residues 1133, 1139, 1140,
and 1141 with alanine. We found that the mutant protein was
still able to promote nascent DNA degradation (Figure S3C).
This result implies that while they may contribute,epleted Cells
dation was analyzed after HU treatment (2 mM, 4 h). Left, whole-cell extracts
ion. Right, IdU:CldU ratios.
leted cells, either mock treated or treated with 50 mM mirin to inhibit MRE11
3 cells. Cells were treated with HU and degradation analyzed as in (A) and (B).
erexpressed in HEK293 cells transfected with siRIF1 or siControl. Cells were
G-WRN was immunoprecipitated and analyzed by mass spectrometry (MS).
. MS1 values for each site were normalized by the summed intensities of total
endent biological replicates.
phosphorylation of these four residues is dispensable for
degradation. It seems likely therefore that other phosphosites
exist, not identified by our experiments, that are also regulated
by RIF1 and important for the control of WRN helicase.
The MCM complex is well characterized as a target for
dephosphorylation by RIF1-PP1, counteracting the phosphory-
lation by DDK that triggers replication initiation. We therefore
tested whether the MCM hyperphosphorylation characteristic
of RIF1-deficient cells could contribute to the overresection
phenotype. We found that artificially reducing MCM phosphory-
lation levels (by using XL-413 to inhibit DDK) did not prevent
nascent DNA resection in HU-treated cells lacking RIF1 (Fig-
ure S4C), suggesting that the MCM complex is not the RIF1-
PP1 dephosphorylation target relevant for nascent DNA
protection.
DNA2-Dependent Resection Compromises Genomic
Stability in RIF1-Depleted Cells
To investigate the biological consequences of the absence of
RIF1 from replication forks challenged by HU, we tested for the
appearance of phosphorylated RPA (Ser4/8) that is indicative
of DNA damage response activation upon replication stress
(Ashley et al., 2014). RIF1 depletion caused an increase in the
percentage of cells displaying the phospho-RPA signal after
HU treatment (Figure 4A, left and center panels). This increase
was significantly suppressed by simultaneous DNA2 depletion,
consistent with RPA phosphorylation resulting from the action
of DNA2. Similar effects were observed when phospho-RPA in-
tensity was measured specifically in the S phase cell population
(Figure 4A, right panel). We next carried out comet assay exper-
iments in alkaline conditions to detect single and double DNA
strand breaks. While HU treatment alone did not detectably in-
crease DNA damage, RIF1-depleted HU-treated cells showed
a significantly increased tail moment, indicative of an accumula-
tion of broken DNA (Figure 4B). The increased tail moment was
greatly reduced when DNA2 was depleted in addition to RIF1,
strongly indicating that the DNA2-dependent degradation of
the stalled forks in RIF1-deficient cells is responsible for the
accumulation of DNA damage. The assessment of breaks was
carried out in cells collected immediately after a 4-h treatment
with HU, suggesting that the damage accumulation arises
directly from replication-associated problems rather than from
consequential problems at later cell-cycle stages, such as
mitotic abnormalities. We found, however, that depletion of
DNA2 was not able to prevent the sensitivity of RIF1-depleted
cells to HU (Figure S4D), perhaps because RIF1 has other,
DNA2-independent, important roles in enabling the recovery of
cells from replication inhibition.
DISCUSSION
The resultsdescribedhere illuminate the importanceof thehuman
RIF1 protein in maintaining the integrity of nascent DNA when
replication is challenged. Budding yeast studies suggest that
this control by RIF1 is evolutionarily conserved (Hiraga et al.,
2018), but provide no information on the mechanism. Here, we
have shown that RIF1 must interact with PP1 to prevent the
degradation of nascent DNA at stalled forks. We identified theDNA2-WRN nuclease-helicase complex as principally respon-
sible for degradation. We found that RIF1 regulates WRN phos-
phorylation at a group of sites implicated in controlling its function
in resection.WRNmay therefore represent an important target for
RIF1-PP1 in suppressing unscheduled degradation at blocked
forks. Mutating the identified sites to prevent their phosphoryla-
tion did not, however, prevent WRN from supporting nascent
DNA resection (Figure S3C), indicating that other phosphosites
are likely to contribute (perhaps redundantly) to controlling resec-
tion by DNA2-WRN. Additional relevant target sites for dephos-
phorylation by RIF1-PP1 could be on WRN or other proteins,
with DNA2 itself being one potential candidate. Little is known
about any importance of DNA2 phosphorylation in higher eukary-
otes. However, in budding yeast Cdk1-dependent phosphoryla-
tion of Dna2 promotes the resection of DSBs (Chen et al., 2011),
while in fission yeast, the Cds1 kinase phosphorylates Dna2 on
S220 to regulate its association with stalled forks and control its
nuclease activity, in turn modulating the formation or stability of
reversed forks (Huetal., 2012). ThisS220 residue isnotconserved
in mammals, but human DNA2 may nonetheless be CDK regu-
lated. We did not, however, identify DNA2 as a candidate target
of RIF1 in chromatin proteomics analysis (Hiraga et al., 2017).
RIF1 therefore joins a group of proteins, including Abro1,
Bod1L, and CtIP, suggested to control the rate of DNA2-medi-
ated resection at stalled replication forks. It remains unclear
exactly how these proteins affect DNA2 nuclease activity. Than-
gavel et al. (2015) showed that after long periods of replication
inhibition, DNA2-mediated resection of DNA occurs even in
normal cells. We therefore suspect that in the absence of
RIF1-PP1, a physiological resection mechanism that normally
processes stalled forks is accelerated, rather than an entirely
aberrant novel mechanism arising. This suggestion is also
consistent with our finding that forks can restart normally
following fork blockage in the absence of RIF1 (Figure S1D).
Our results are consistent with the requirement for DNA2 in
fork restart (Thangavel et al., 2015) since DNA2 was present in
our restart experiment.
The function of RIF1 in protecting nascent DNA appears
distinct from the BRCA-dependent pathway of fork protection.
In BRCA2-defective cells, MRE11 nuclease mediates the degra-
dation of nascent DNA at the stalled forks, but MRE11 is not
required for the DNA degradation occurring in the absence of
RIF1 (Figures 3B and S2C). At DSBs, RIF1 cooperates with
53BP1 to block BRCA-mediated resection and promote non-ho-
mologous end joining (NHEJ) repair. At stalled forks RIF1, how-
ever, appears to act independently of 53BP1, since 53BP1-defi-
cient mouse B cells were reported to be proficient in protecting
nascent DNA upon genotoxic stress (Ray Chaudhuri et al., 2016).
Therefore, distinct mechanisms seem to protect nascent DNA
from degradation upon replication blockage, reflecting the regu-
lation of different nucleases, and many questions remain to be
solved about how different pathways intercommunicate to pro-
tect nascent DNA at blocked forks and process the structures
formed to restart replication. It seems likely that the nuclease ac-
tivities of MRE11, DNA2, and EXO1 must be separately downre-
gulated by various pathways to prevent nascent DNA degrada-
tion. Here, we have identified RIF1-PP1 regulation of the
DNA2-WRN complex as an important part of this controlCell Reports 27, 2558–2566, May 28, 2019 2563
AB
Figure 4. Nucleolytic Processing by DNA2 Underlies DNA Damage Accumulation in the Absence of RIF1
(A) RPA phosphorylation (Ser4/8) was analyzed by immunofluorescence in U2OS cells transfected with the indicated siRNAs. Cells were collected and fixed in
unperturbed conditions or after treatment with 2 mM HU for 4 hours. Cells were pulse labeled for 30 min with 5-ethynyl-2ʹ-deoxyuridine (EdU) before collection
(untreated samples) or before HU treatment. Left: representative images of phospho-RPA signal. Scale bars, 20 mm. Center: the percentage of cells positive for
phospho-RPA (Ser4/8) was quantified for each condition (n = 3 biological replicates). Error bars represent SD. Right: phospho-RPA integrated intensity was
measured in EdU+ cells.
(B) DNA breaks were evaluated by alkaline comet assay in U2OS cells transfected with siRIF1 and/or siDNA2, as indicated. Left: representative images. Scale
bars, 5 mm. Right: Olive tail moment values from comet assay, with 2 mM HU treatment for 4 h, as indicated.
ns, not significant; *p% 0.05; ****p% 0.0001.
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network, acting to preserve recently synthesized DNA at stalled
forks from DNA2-dependent degradation and limiting the accu-
mulation of DNA damage.
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Mouse monoclonal anti-BRCA2 [2B] Millipore Cat# OP95; RRID:AB_2067762
Mouse monoclonal anti-CtIP [D-4] Santa Cruz Cat# sc-271339; RRID:AB_10608728
Rabbit polyclonal anti-BLM Abcam Cat# ab2179; RRID:AB_2290411
Mouse monoclonal anti-WRN (D-6) Santa Cruz Cat# sc-376182; RRID:AB_10988219
Mouse monoclonal anti-FLAG M2 Sigma Cat# F1804; RRID:AB_262044
Rabbit polyclonal anti-RAD51 (H-92) Santa Cruz Cat# sc-8349; RRID:AB_2253533
Mouse monoclonal anti-SMARCAL1 (E-12) Santa Cruz Cat# sc-376377; RRID:AB_10987841
Rabbit polyclonal anti-phospho MCM2 (S53) Bethyl Cat# A300-756A; RRID:AB_669843
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Rat monoclonal anti-BrdU [BU1/75 (ICR1)] Abcam Cat# ab6326; RRID:AB_305426
Mouse monoclonal anti-BrdU BD Biosciences Cat# 347580; RRID:AB_400326
Mouse monoclonal anti-ssDNA, clone 16-19 Millipore Cat# MAB3034; RRID:AB_11212688
Goat anti-Rat IgG (H+L), Alexa Fluor 594 Thermo Fisher Cat# A-11007; RRID:AB_10561522
Goat anti-Mouse IgG1, Alexa Fluor 488 Thermo Fisher Cat# A-21121; RRID:AB_2535764
Goat anti-Mouse IgG2a, Alexa Fluor 350 Thermo Fisher Cat# A-21130; RRID:AB_2535770
Goat anti-Mouse IgG, Cyanine5 conjugated Thermo Fisher Cat# A10524; RRID:AB_2534033
Goat anti-Rabbit IgG, Cyanine3 conjugated Thermo Fisher Cat# A10520; RRID:AB_2534029
Chemicals, Peptides, and Recombinant Proteins
Hydroxyurea Sigma Cat# H8627
Doxycycline hyclate Sigma Cat# D9891
Tautomycetin Tocris Cat# 2305
Mirin Sigma Cat# M9948
NSC-105808 (DNA2 inhibitor) Gift from Alessandro Vindigni,
described in (Kumar et al., 2017)
N/A
XL-413 Gift from Peter Cherepanov N/A
Critical Commercial Assays
Click-iT Plus EdU Alexa Fluor 647 Imaging Kit Thermo Fisher Cat# C10640
OxiSelect Comet Assay Kit (3-Well Slides) Cell Biolabs Cat# STA-350
Experimental Models: Cell Lines
Flp-In T-REx 293 Invitrogen Cat# R78007
HEK293 (GFP) Hiraga et al., 2017 N/A
HEK293 (GFP-RIF1) Hiraga et al., 2017 N/A
HEK293 (GFP-RIF1-pp1bs) Hiraga et al., 2017 N/A
U2OS Berndt M€uller lab N/A
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MRE11 ON-TARGETplus SMARTpool - Human Dharmacon Cat# L-009271-00
CtIP ON-TARGETplus SMARTpool - Human Dharmacon Cat# L-011376-00
EXO1 ON-TARGETplus SMARTpool - Human Dharmacon Cat# L-013120-00
BLM ON-TARGETplus SMARTpool - Human Dharmacon Cat# L-007287-00
WRN ON-TARGETplus SMARTpool - Human Dharmacon Cat# L-010378-00
WRN siRNA, targeting sequence
50-GUGCCAUUAAAUAGGGAAAUU-30
Dharmacon N/A
RAD51 ON-TARGETplus SMARTpool - Human Dharmacon Cat# L-003530-00
SMARCAL1 ON-TARGETplus SMARTpool - Human Dharmacon Cat# L-013058-00
Recombinant DNA
pCMV-Flag-WRN-WT Gift from Pietro Pichierri
(Palermo et al., 2016)
N/A
pCMV-Flag-WRN-4A This paper N/A
Software and Algorithms
Prism 7 GraphPad https://www.graphpad.com/
scientific-software/prism/
ImageJ ImageJ Software https://imagej.nih.gov/ij/
CellProfiler CellProfiler Software https://cellprofiler.org/
OpenComet OpenComet Software http://www.cometbio.org/
MaxQuant Max Planck Institute https://www.maxquant.org/CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Anne D.
Donaldson (a.d.donaldson@abdn.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
U2OS cells (female) and HEK293-derived cells (female fetus) were cultured in Dulbecco’s modified Eagle’s medium (DMEM), sup-
plemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin, and maintained in an incubator at 37C and 5%
CO2. HEK293-derived cell lines containing GFP, GFP-RIF1 or GFP-RIF1-pp1bs constructs were previously generated using the
Flp-In T-REx system (Invitrogen) (Hiraga et al., 2017). Tetracycline-free serum was used for the maintenance of the cell lines with
the doxycycline-inducible constructs mentioned above.
METHOD DETAILS
Drug treatments
HU (Sigma) was used at a concentration of 2mMor 4mM. Tautomycetin (Tocris) was used at a concentration of 5 mM. DNA2 inhibitor
NSC-105808 (Kumar et al., 2017) was added to the cells at a final concentration of 0.3 mM and Mirin (Sigma) was used at a concen-
tration of 50 mM. XL-413 was used at a final concentration of 10 mM.
Construction of WRN mutant plasmid
Plasmid pCMV-Flag-WRN-4A was created by replacing a 1.2 kb PshAI-BglII segment of the plasmid pCMV-Flag-WRN-WT (kindly
gifted by Pietro Pichierri) with a synthetic DNA fragment containing four S to A substitutions at Ser-1133, 1139, 1140, and 1141.
The sequence of the synthetic DNA is available upon request. The DNA sequence was confirmed for the entire Flag-WRN coding
sequences, and part of the promoter.
siRNA transfection and DNA transfection
Control siRNA against Luciferase (D-001100-01) and siRNA against RIF1 (D-027983-02), DNA2 (L-026431-01), MRE11
(L-009271-00), BRCA2 (L-003462-00), CtIP (L-011376-00), EXO1 (L-013120-00), BLM (L-007287-00), WRN (L-010378-00), WRN
30UTR custom, RAD51 (L-003530-00) and SMARCAL1 (L-013058-00) were purchased from Dharmacon. For protein knockdown,e2 Cell Reports 27, 2558–2566.e1–e4, May 28, 2019
cells were transfected with the indicated siRNAs at a final concentration of 50 nM (in co-transfections 50 nM of each siRNAwas used)
using Lipofectamine RNAiMAX reagent (Thermo Fisher). The day after siRNA transfection cells were re-seeded and grown for a
further 48 hours, when cells were collected.
For overexpression of Flag-WRN constructs cells were transiently transfected with 2 mg of pCMV-Flag-WRN-WT or pCMV-Flag-
WRN-4A using Lipofectamine 3000 Reagent (Thermo Fisher).
DNA fiber assay
Cells were pulse-labeled with 50 mM CldU for 20 min, followed by another pulse of 250 mM IdU for 20 min. Then, fork stalling was
induced by addition of 2 mM HU for 4 hours. Cells were harvested and DNA fibers prepared as previously described (Mouro´n
et al., 2013). Cells were lysed on a microscope slide with spreading buffer (200 mM Tris pH 7.4, 50 mM EDTA, 0.5% SDS). After
6 min of incubation, the slides were tilted to allow the DNA suspension to run slowly and spread down the slide. Slides were fixed
in cold (20C) methanol-acetic acid (3:1). DNA was denatured by incubation in 2.5 M HCl at RT for 30 min. Slides were blocked
and incubated with the following primary antibodies for 1 hour at RT in humidity chamber (anti-CldU, Abcam ab6326, 1:100; anti-
IdU, BD 347580, 1:100; anti-ssDNA, Millipore MAB3034, 1:100). After washes with PBS, the slides were incubated with the following
secondary antibodies (anti-rat IgG Alexa Fluor 594, Molecular Probes A-11007; anti-mouse IgG1 Alexa Fluor 488, Molecular Probes
A-21121; anti-mouse IgG2a Alexa Fluor 350, Molecular Probes A-21130). Slides were air-dried and mounted with Prolong (Invitro-
gen). DNA fibers were imaged under a Zeiss Axio Imager and analyzed using ImageJ. CldU and IdU tract lengths were measured in
double-labeled forks and the IdU/CldU ratio was used to quantify the degree of nascent DNA resection. Experiments in Figures 1B,
3A, 3C, S1B, S2E, S4A, and S4B show amalgamated results and median from two biological replicates with at least 75 fibers
analyzed per condition in each replicate. Experiment in Figures 1C, 3B, S2A–S2D, S3C, and S4C show results and median from
one experiment with at least 100 fibers analyzed per condition. Analysis of statistical significance was performed using aMann-Whit-
ney test (GraphPad Prism).
Western blotting and chromatin fractionation
For whole cell protein extraction cells were lysed in SDS buffer (125 mM Tris-HCl pH 6.8, 4% SDS, 20% glycerol) supplemented with
protease and phosphatase inhibitors. 50 mg of protein was separated by SDS-PAGE using precast gels (Bio-Rad), transferred to
PVDF membranes and probed with the indicated primary antibodies. After incubation with the corresponding HRP-conjugated sec-
ondary antibodies, the blots were developed with Clarity ECL reagents (Bio-Rad) and imaged with the ChemiDoc system (Bio-Rad).
For chromatin fractionation, cell pellets were resuspended in CSK buffer (10 mM PIPES-NaOH pH 6.8, 300 mM sucrose, 100 mM
NaCl, 3 mM MgCl2) supplemented with protease and phosphatase inhibitors. After incubation for 10 min on ice, cells were centri-
fuged at 2,500 g for 3 min and soluble and insoluble fractions separated. The insoluble, chromatin fraction was further resuspended
in CSK buffer and incubated 30min in the presence of benzonase on ice. Samples were thenmixed with Laemmli Buffer 2x and incu-
bated for another 30 min at 65C.
The following primary antibodies were used for immunoblotting: RIF1 (A300-568A, Bethyl Laboratories), phospho-CHK1 (Ser345)
(#2348, Cell Signaling), DNA2 (ab96488, Abcam), MRE11 (ab214, Abcam), BRCA2 (OP95, Millipore), CtIP (sc-271339, Santa Cruz
Biotechnology), BLM (ab2179, Abcam), WRN (sc-376182, Santa Cruz Biotechnology), FLAG-M2 (F1804, Sigma), RAD51 (sc-
8349, Santa Cruz Biotechnology), SMARCAL1 (sc-376377, Santa Cruz Biotechnology), phospho-MCM2 (Ser53) (A300-756A, Bethyl
Laboratories).
Immunofluorescence
For RPA and phospho-RPA immunostaining, cells were grown on coverslips and pre-extracted on ice with pre-extraction buffer
(50 mM NaCl, 300 mM sucrose, 0.5% Triton X-100, 3 mM MgCl2, 20 mM HEPES pH 7.9). After fixation with 4% paraformaldehyde,
cells were permeabilized by incubating again with pre-extraction buffer for additional 10 min. Coverslips were blocked with 2.5%
BSA, 10% Goat Serum in PBS, and incubated with primary antibody at RT for 2 hours, followed by incubation with the secondary
antibody for 1 hour. In the case of EdU (5-ethynyl-20-deoxyuridine) incorporation, cells were pulse-labeled at a concentration of
20 mM for 30 min. EdU detection was performed using the Click-iT Plus EdU Alexa Fluor 647 Imaging Kit from Thermo Fisher,
following manufacturer’s instructions. Primary antibodies were anti-RPA32 (ab2175, Abcam) and anti-phospho RPA32 (S4/S8)
(A300-245A, Bethyl Laboratories). Secondary antibodies were anti-mouse Cy5 (A10524, Thermo Fisher) and anti-rabbit Cy3
(A10520, Thermo Fisher). Coverslips were finally washed with PBS, stained with DAPI and mounted with Prolong (ThermoFisher),
before image acquisition in Zeiss Axio Imager microscope. For phospho-RPA quantification, the percentage of cells with positive
signal for Ser4/Ser8 phosphorylation was quantified. For evaluation of fluorescence intensity, integrated intensity was measured
in nuclei areas of whole cell population or EdU positive cells. Median values are represented on the scattered dot plots. Images
were analyzed using ImageJ and CellProfiler software.
Clonogenic assay
For colony survival studies, 24 h after siRNA-mediated protein knockdown, cells were plated at low density in 6 well/plates. One day
later, cultures were treated with HU at the indicated times and concentrations. HU-containing media was then replaced with freshCell Reports 27, 2558–2566.e1–e4, May 28, 2019 e3
media and cells were kept for 7 days in culture to allow colony formation. Colonies were fixedwith 4%paraformaldehyde and stained
with 0.02% Crystal Violet. Colonies were counted and the surviving fraction calculated relative to the siControl untreated sample.
Alkaline comet assay
Alkaline comet assays were performed according to instructions using OxiSelect Comet Assay Kit (Cell Biolabs). Briefly, harvested
cells were mixed with low melting agarose and transferred to an OxiSelect Comet slide. Slides were immersed in lysis buffer for
60 min at 4C. Lysis buffer was replaced with alkaline solution (300 mM NaOH, pH > 13, 1 mM EDTA) and samples were kept in
the dark for 30 min. Slides were transferred to an electrophoresis chamber filled with alkaline solution and electrophoresis was per-
formed for 15 min (1 V/cm). DNA was stained with Vista Green DNA Dye and images were captured by fluorescence microscopy
(Zeiss Axio Imager). Comets were scored and tail moment was analyzed using the OpenComet software. The median value is shown
on the dot plot.
Immunoprecipitation and MS analysis
pCMV-Flag-WRN and plasmids derived from it were transiently transfected to achieve overexpression of WRN constructs. For Flag-
WRN immunoprecipitation (IP), cells were collected with a scraper in cold PBS. Cells were lysed in 50 mM Tris-Cl pH 7.5, 150 mM
NaCl, 0.5% NP-40, 2 mM MgCl2, supplemented with protease/phosphatase inhibitors and benzonase. 1 mg of protein lysate was
incubated overnight with anti-Flag M2 antibody (F1804, Sigma) coupled to Dynabeads protein G. After two washes with lysis buffer,
beads were further washed with 100 mM ammonium bicarbonate. Immunoprecipitates were processed for on-beads digestion by
Trypsin essentially as described (Mohammed et al., 2016). Peptides were then reduced with 10 mM TCEP and alkylated with
15 mM Iodoacetamide. Peptides were analyzed using an Orbitrap Q Exactive Plus mass spectrometer equipped with nano-LC
C18 liquid chromatography over 60-min elution gradient. The raw MS datasets were analyzed for label-free quantification by
MaxQuant software (version 1.6.2.3). MS1 Intensity of each phosphorylation site was normalized by summed MS1 intensities of
WRN in each sample. The normalized phospho/WRN values (expressed as ppm of total WRN) between samples were compared.
Since phosphorylations at S1139, S1140, or S1141 could not be unambiguously distinguished, values at these sites were summed.
QUANTIFICATION AND STATISTICAL ANALYSIS
For column graphs, the mean ± standard deviation (SD) is shown and statistical analysis using Student’s t test was performed. For
scatter dot plots (IdU/CldU ratio in fork protection assays, integrated intensity in immunofluorescence assays and tail moment in
comet assays), the median value is shown and data were analyzed and statistical significance calculated using Mann-Whitney
test for non-parametric distributions. Statistical analysis was performed with GraphPad Prism software (v.7) (ns not significant;
* p% 0.05; ** p% 0.01; *** p% 0.001; **** p% 0.0001).e4 Cell Reports 27, 2558–2566.e1–e4, May 28, 2019
